Global Apheresis Market, By Product (Apheresis Devices, Apheresis Disposables), Disease (Haematology, Autoimmune Diseases, Cardiovascular Diseases, Neurology, Metabolic Disorders, Renal Diseases), Procedure (Plasmapheresis, LDL-apheresis, Plateletpheresis, Photopheresis, Leukapheresis, Erythrocytapheresis, Therapeutic Cytapheresis), Technology (Centrifugation, Membrane Separation), End-User (Blood Collection Centres, Hospitals, Ambulatory Centres) – Industry Trends and Forecast to 2029
Market Analysis and Size
There has been in an increase in the use of apheresis in clinically ill patients lately, and is utilized as the primary therapy or as an adjunct to other therapies. The prevalence of chronic diseases is rising the demand for apheresis.
- This procedure is widely performed for the blood donation component. Global Apheresis Market was valued at USD 2.20 billion in 2021 and is expected to reach USD 4.01 billion by 2029, registering a CAGR of 8.95% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Apheresis refers to the medical technology that is usually deployed for the separation of different component of blood or purification of the blood. The technology consists of removing the blood from the patients of donor, and collecting it into an apparatus that separates the desired component from the blood. During the process the rest of the blood is sent back to the donor or patients.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Forecast Period
|
2022 - 2029
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Apheresis Devices, Apheresis Disposables), Disease (Haematology, Autoimmune Diseases, Cardiovascular Diseases, Neurology, Metabolic Disorders, Renal Diseases), Procedure (Plasmapheresis, LDL-apheresis, Plateletpheresis, Photopheresis, Leukapheresis, Erythrocytapheresis, Therapeutic Cytapheresis), Technology (Centrifugation, Membrane Separation), End-User (Blood Collection Centres, Hospitals, Ambulatory Centres)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Fresenius Kabi AG (Germany), Kidde-Fenwal Inc. (US), Haemonetics Corporation (US), Isto Biologics (US), Asahi Kasei Medical Co. Ltd. (Japan), TERUMO BCT, INC (US), Otsuka Holdings Co., Ltd. (Japan), Bioelettronica Srl (Italy), HemaCare (US), TORAY INDUSTRIES, INC (Japan), Mallinckrodt (US), KANEKA CORPORATION (Japan), B. Braun Melsungen AG (Germany), Cerus Corporation (US), KAWASUMI LABORATORIES INC. (Japan), Nikkiso Co., Ltd. (Japan), Grifols, S.A. (Spain), and Medica S.p.A. (Italy) among others
|
Apheresis Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
-
Prevalence of Chronic Diseases
The rise in the prevalence of chronic diseases and increase in the number of trauma and injury cases across the globe acts as one of the major factors driving the growth of apheresis market.
-
Demand for Source Plasma
The surge in demand for demand for source plasma from biopharmaceutical companies accelerate the market growth.
-
Demand for Blood Components
The increase in the demand for blood components and rise in concerns regarding blood safety will assist in the expansion of the apheresis market.
-
Favorable Reimbursement
The presence of favourable reimbursement for apheresis procedures further influence the market.
Opportunities
-
Leukemia and Pediatric Patients
The increase in demand for apheresis for leukemia and pediatric patients extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, increase in the number of complex surgical procedures will further expand the market.
Restraints/Challenges
-
High Cost of Apheresis Devices
On the other hand, high cost of apheresis devices and therapeutic apheresis procedures and installation of apheresis devices is expected to obstruct market growth. Also, fewer blood donations using apheresis due to lack of awareness is projected to challenge the apheresis market in the forecast period of 2022-2029.
This apheresis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on apheresis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Apheresis Market
The medical services such as apheresis witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the blood purification surgeries is expected in the post-COVID owing to the easing of restrictions.
Recent Development
- Haemonetics Corporation acquired privately-held Cardiva Medical, Inc., based in Santa Clara, California in January’2021. The agrrement was made to provide better patient outcomes.
Global Apheresis Market Scope and Market Size
The apheresis market is segmented on the basis of product, disease, procedure, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Apheresis Devices
- Apheresis Disposables
On the basis of product, the apheresis market is segmented into apheresis devices and apheresis disposables. Apheresis devices are further segmented into centrifugal apheresis devices and membrane separation devices.
Disease
- Haematology
- Autoimmune Diseases
- Cardiovascular Diseases
- Neurology
- Metabolic Disorders
- Renal Diseases
Based on disease, the apheresis market is segmented into haematology, autoimmune diseases, cardiovascular diseases, neurology, metabolic disorders and renal diseases.
Procedure
- Plasmapheresis
- LDL-apheresis
- Plateletpheresis
- Photopheresis
- Leukapheresis
- Erythrocytapheresis
- Therapeutic Cytapheresis
Based on procedure, the apheresis market is segmented into plasmapheresis, LDL-apheresis, plateletpheresis, photopheresis, leukapheresis, erythrocytapheresis, and therapeutic cytapheresis.
Technology
- Centrifugation
- Membrane Separation
Based on technology, the apheresis market is segmented into centrifugation and membrane separation.
End-User
- Blood Collection Centres
- Hospitals
- Ambulatory Centres
The apheresis market is also segmented on the basis of end-user into blood collection centres, hospitals and ambulatory centres.
Apheresis Market Regional Analysis/Insights
The apheresis market is analysed and market size insights and trends are provided by country, product, disease, procedure, technology and end-user as referenced above.
The countries covered in the apheresis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the apheresis market because of the large number of people suffering from different chronic diseases within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the demand for different blood components for the patients in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The apheresis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for apheresis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the apheresis market. The data is available for historic period 2010-2020.
Competitive Landscape and Apheresis Market Share Analysis
The apheresis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to apheresis market.
Some of the major players operating in the apheresis market are Fresenius Kabi AG (Germany), Kidde-Fenwal Inc. (US), Haemonetics Corporation (US), Isto Biologics (US), Asahi Kasei Medical Co. Ltd. (Japan), TERUMO BCT, INC (US), Otsuka Holdings Co., Ltd. (Japan), Bioelettronica Srl (Italy), HemaCare (US), TORAY INDUSTRIES, INC (Japan), Mallinckrodt (US), KANEKA CORPORATION (Japan), B. Braun Melsungen AG (Germany), Cerus Corporation (US), KAWASUMI LABORATORIES INC. (Japan), Nikkiso Co., Ltd. (Japan), Grifols, S.A. (Spain), and Medica S.p.A. (Italy) among others.
SKU-